Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). New drugs, new targets: good news on the horizon.
Flexner
Charles
C
D065100:CCR5 Receptor Antagonists; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000627:therapeutic use*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013386:Succinates / Q000627:therapeutic use*; D014315:Triterpenes / Q000627:therapeutic use*; D053978:Pentacyclic Triterpenes
D065100:CCR5 Receptor Antagonists; D019428:HIV Integrase Inhibitors; D017320:HIV Protease Inhibitors; D019718:Receptors, CXCR4; D018894:Reverse Transcriptase Inhibitors; D013386:Succinates; D014315:Triterpenes; C479935:bevirimat; D053978:Pentacyclic Triterpenes